American Journal of Infection Control

Clostridioides difficile infection (CDI) is recognized as the leading cause of nosocomial diarrhea associated with the use of antibiotics and the most frequent healthcare-associated infection in high-income countries1. In 2017, this infection caused

In March 2020, the World Health Organization (WHO) declared the novel coronavirus pandemic (COVID-19) that had spread rapidly around the world and caused thousands of deaths.1 As of 18 September 2021, more than 227 million cases and 4.67 million

Nurses play an important role in the vaccine readiness process and high vaccination rates among nurses are essential to ensuring successful vaccination programs. This study sought to examine whether the intention to get vaccinated varied by race

Clostridioides difficile (C. difficile) is a leading cause of nosocomial infections. It is a spore-forming anaerobic bacillus that is mainly transmitted through direct or indirect contact with infected patients and asymptomatic carriers.1,2 Patients

Due to the ongoing coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization (WHO) recommended on March 16, 2020 to carry out nasopharyngeal swabs for the detection of SARS-CoV-2 as extensively as possible to contain the pandemic1:

Asymptomatic bacteriuria (ASB), or bacteria in the urine when the patient lacks an evidence-based symptom of a urinary tract infection (UTI), occurs at varying rates across different populations.1 The prevalence in healthy adult men and women has

COVID-19 was declared a global pandemic on March 11, 2020 1. The pandemic has substantially affected both the mental health of people around the world, as well as the delivery of psychiatric health care. Patients with psychiatric conditions

The members of the Burkholderia cepacia complex (Bcc) are Gram-negative bacilli which are increasingly being reported as opportunistic human pathogens.1, 2, 3 Bcc rarely causes disease in immunocompetent individuals and is recognized as a serious

Health care associated infections (HAI) are responsible for increased length of stay, cost of hospitalization, and high morbidity and mortality. Some authors report that 10-70% of infections can be avoided if prevention and control measures (bundles)

COVID-19 pneumonia is associated with a mortality up to 20% varying by country1 with the number of global deaths over 5 million.2 Antibiotics have been extensively used in COVID-19 patients in intensive care units (ICUs) without a clear indication.3